Targeting antigens to murine and human M-cells with Aleuria aurantia lectin-functionalized microparticles.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Immunology Letters

• Publication date

  2005-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.IMLET.2005.03.020PMID 15913790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Challenges in creating a vaccine to prevent hepatitis E.

  2005cited by this paper
• Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures.

  2004cited by this paper
• M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy.

  2004cited by this paper
• A Novel Approach to Specific Allergy Treatment: The Recombinant Fusion Protein of a Bacterial Cell Surface (S-Layer) Protein and the Major Birch Pollen Allergen Bet v 1 (rSbsC-Bet v 1) Combines Reduced Allergenicity with Immunomodulating Capacity1

  2004cited by this paper
• Tolerance, not immunity, crucially depends on IL-2

  2004cited by this paper
• Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes.

  2004cited by this paper
• Acquired and natural memory T cells join forces at the mucosal front line

  2004cited by this paper
• The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling

  2004cited by this paper
• Intestinal IgA synthesis: regulation of front-line body defences

  2003cited by this paper
• Anatomical basis of tolerance and immunity to intestinal antigens

  2003cited by this paper
• The binding characteristics and utilization of Aleuria aurantia, Lens culinaris and few other lectins in the elucidation of fucosyltransferase activities resembling cloned FT VI and apparently unique to colon cancer cells.

  2003cited by this paper
• Crystal Structure of Fungal Lectin

  2003cited by this paper
• The Viral σ1 Protein and Glycoconjugates Containing α2-3-Linked Sialic Acid Are Involved in Type 1 Reovirus Adherence to M Cell Apical Surfaces

  2003cited by this paper
• The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces.

  2003cited by this paper
• Crystal structure of fucose-specific lectin from Aleuria aurantia binding ligands at three of its five sugar recognition sites.

  2003cited by this paper
• Transport of Chitosan Microparticles for Mucosal Vaccine Delivery in a Human Intestinal M-cell Model

  2002cited by this paper
• Lymphoepithelial Interactions Trigger Specific Regulation of Gene Expression in the M Cell-Containing Follicle-Associated Epithelium of Peyer’s Patches1

  2002cited by this paper
• Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase

  2001cited by this paper
• Oral vaccination in man using antigens in particles: current status.

  2001cited by this paper
• The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145.

  2001cited by this paper
• Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells

  2001cited by this paper
• Influenza virus neuraminidase inhibitors.

  2000cited by this paper
• Expression of specific markers and particle transport in a new human intestinal M-cell model.

  2000cited by this paper
• Lectin-mediated mucosal delivery of drugs and microparticles.

  2000cited by this paper
• Much ado about M cells.

  2000cited by this paper
• Much ado about M cells.

  2000cited by this paper
• Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: a technical update.

  2000cited by this paper
• Human Intestinal M Cells Display the Sialyl Lewis A Antigen

  1999cited by this paper
• M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process.

  1999cited by this paper
• Molecules controlling lymphocyte migration to the gut

  1999cited by this paper
• PLANT LECTINS FOR ORAL DRUG DELIVERY TO DIFFERENT PARTS OF THE GASTROINTESTINAL TRACT

  1999cited by this paper
• Bioadhesive Drug Delivery Systems : Fundamentals, Novel Approaches, and Development

  1999cited by this paper
• Microparticle targeting to M cells.

  1998cited by this paper
• Studying M cells and their role in infection.

  1998cited by this paper
• Lectin Histochemistry Reveals the Appearance of M-cells in Peyer's Patches of scid Mice After Syngeneic Normal Bone Marrow Transplantation

  1998cited by this paper
• M-Cell Surface β1 Integrin Expression and Invasin-Mediated Targeting of Yersinia pseudotuberculosis to Mouse Peyer’s Patch M Cells

  1998cited by this paper
• Targeting to intestinal M cells.

  1996cited by this paper
• Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches

  1996cited by this paper
• Variations in lectin binding properties of intestinal M cells.

  1995cited by this paper
• Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches

  1994cited by this paper
• Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain.

  1994cited by this paper
• A Drug Absorption Model Based on the Mucus Layer Producing Human Intestinal Goblet Cell Line HT29-H

  1993cited by this paper
• M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration.

  1986cited by this paper
• The induction of tolerance to a soluble protein antigen by oral administration.

  1974cited by this paper
• The induction of tolerance to a soluble protein antigen by oral administration.

  1974cited by this paper

• Oral Vaccines for Prevention of Bacterial Infections: Development Strategies and Prospects

  2024cites this paper
• Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions

  2024cites this paper
• Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide

  2023cites this paper
• Targeting cell surface glycans with lectin-coated fluorescent nanodiamonds

  2022cites this paper
• Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy.

  2022cites this paper
• Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

  2021cites this paper
• Spray-drying for the formulation of oral drug delivery systems

  2020cites this paper
• Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

  2020cites this paper
• Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems.

  2020cites this paper
• An ex vivo investigation of the intestinal uptake and translocation of nanoparticles targeted to Peyer's patches microfold cells.

  2020cites this paper
• Oral allergen immunotherapy by targeting Peyer’s patches

  2019cites this paper
• Development of a M cell-targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17.

  2019cites this paper
• Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.

  2018cites this paper
• Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting

  2018cites this paper
• Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.

  2017cites this paper
• Current state and challenges in developing oral vaccines.

  2017cites this paper
• M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis

  2016cites this paper
• Lectin-coated particulate delivery systems for oral administration

  2016cites this paper
• Mucosal Delivery of Particulate Breast Cancer Vaccine

  2015cites this paper
• Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.

  2014cites this paper
• M cell specific markers in man and domestic animals: valuable tools in vaccine development.

  2013cites this paper
• Oral microparticulate vaccine for melanoma using M-cell targeting

  2012cites this paper
• Drug Targeting in IBD Treatment – Existing and New Approaches

  2012cites this paper
• Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

  2012cites this paper
• Use of lectin-functionalized particles for oral immunotherapy.

  2012cites this paper
• Formulation and evaluation of a particulate oral breast cancer vaccine.

  2012cites this paper
• Spray-dried microparticles: a potential vehicle for oral delivery of vaccines

  2012cites this paper
• Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination.

  2012cites this paper
• Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.

  2010cites this paper
• Incorporation of PVMMA to PLGA MS enhances lectin grafting and their in vitro activity in macrophages.

  2010cites this paper
• Improving oral delivery.

  2010cites this paper
• Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.

  2009cites this paper
• M cell-targeted delivery of vaccines and therapeutics

  2008cites this paper
• PLGA microparticles for oral allergen immunotherapy

  2007cites this paper
• Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells.

  2007cites this paper
• Peyer's Patches and M Cells as Potential Sites of the Inflammatory Onset in Crohn's Disease

  2006cites this paper
• Rat, ovine and bovine Peyer's patches mounted in horizontal diffusion chambers display sampling function.

  2006cites this paper
• Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy.

  2006cites this paper
• Characterization of antigen and bacterial transport in the follicle-associated epithelium of human ileum

  2006cites this paper
• Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

  2006cites this paper